Innovation in pharma not a prescription for boosting logistics profits
Forwarders should beware of confusing demand for complex, high-value pharmaceutical therapies with expectations of increased volumes or improved profitability, warned Pharma.Aero secretary general Frank van Gelder this week. He told The Loadstar that the…
Forwarders should beware of confusing demand for complex, high-value pharmaceutical therapies with expectations of increased volumes or improved profitability, warned Pharma.Aero secretary general Frank van Gelder this week.
He told The Loadstar that the days of assuming higher-value goods were a free pass to slap the shipper with higher rates were now in the past.
He said shippers now wanted proof that logistics operators can handle specialist medications and time-sensitive treatments.
“Demand for complex, high-value and time-sensitive therapies can increase, even when traditional tonnage grows more slowly or shifts between modes,” he explained. “Operators must demonstrate what their services actually protect.
This story was originally published by The Loadstar. Read the full story at The Loadstar →




Conversation